𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intralesional interferon-alpha therapy in advanced malignant melanoma

✍ Scribed by Peter Von Wussow; Berthold Block; F. Hartmann; Helmuth Deicher

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
363 KB
Volume
61
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Interferon in combination with vinblasti
Interferon in combination with vinblastine in advanced malignant melanoma. A phase I–II study
✍ Stein Gundersen; A. Flokkmann πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 288 KB πŸ‘ 2 views

Nineteen patients with advanced malignant melanoma were treated with a combination of recombinant alfa-interferon (a-IFN) and vinblastine (VBL). The a-IFN was administered subcutaneously daily at an initial dose of 3 X lo6 IU escalating to a maximal dose of 9 X lo6 U daily for the first 10 weeks fol

Pulmonary side effects of interferon-Ξ± t
Pulmonary side effects of interferon-Ξ± therapy in patients with hematological malignancies
✍ Patrik Anderson; Martin HΓΆglund; Stig RΓΆdjer πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 56 KB

## Abstract Several side effects of interferon‐α‐2b (IFN‐α) therapy have been described. Pulmonary side effects have seldom been reported. The four patients we describe all developed respiratory disorders while being treated with IFN‐α for hematological malignancies. We point out the similarities a